1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Cipher Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne CIP-Isotretinoin, Isotretinoin - Severe Nodular Acne | Phase 3 | Completed | Cipher Pharmaceuticals Inc. | 925 | 2009-09-01 | 2014-07-04 |
Isotretinoin (1)
Canada (1) · United States (1)
Guy Webster, MD (1) · James J. Leyden, MD (1) · Jason A. Gross, PharmD (1)